GlassScriptPhysician profile
Janice A Aguinaldo
NPI 1174992085
$1,704.64
in general payments reported to CMS, 2019-2025
22 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $606 · 2023: $233 · 2024: $388 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $959.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $291.69 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $240.79 | 2022-2024 | Farxiga |
| Novo Nordisk INC | $225.68 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $161.06 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Abbvie INC. | $118.52 | 2021-2022 | |
| Astellas Pharma US INC | $97.82 | 2022 | |
| Glaxosmithkline, LLC. | $80.62 | 2023-2025 | Arexvy, Shingrix |
| Exact Sciences Corporation | $67.56 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Amgen INC. | $59.65 | 2023 | Otezla, Repatha |
| Biohaven Pharmaceutical Holding Company LTD. | $52.84 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $50.88 | 2021 | |
| Boston Scientific Corporation | $45.71 | 2023-2025 | General - Pain Management |
| Viiv Healthcare Company | $31.15 | 2024 | Dovato |
| Kaleo, INC. | $27.53 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.73 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.18 | 2022 | |
| Lifescan, INC. | $20.82 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.26 | 2021 | |
| Abbott Laboratories | $17.53 | 2025 | Freestyle Libre 3 |
| Itamar Medical INC | $17.17 | 2024 | Watchpatone |
| Dexcom, INC. | $17.15 | 2024 | Dexcom G6 Transmitter |
| Nevro Corp. | $16.30 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Aguinaldo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.